Local myofascitis of the deltoid muscle after administration of the AstraZeneca (AZD1222) COVID-19 vaccine: two cases, infectious and inflammatory
Main Authors: | Jong Pil Yoon, MD, Young Soo Jung, MD, Dong Hyun Kim, MD |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2022-08-01
|
Series: | JSES Reviews, Reports, and Techniques |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2666639122000566 |
Similar Items
-
A Battle against COVID-19: Vaccine Hesitancy and Awareness with a Comparative Study between Sinopharm and AstraZeneca
by: Marian S. Boshra, et al.
Published: (2022-02-01) -
Cross-Reactivity between Half Doses of Pfizer and AstraZeneca Vaccines—A Preliminary Study
by: Krzysztof Lukaszuk, et al.
Published: (2022-03-01) -
Crisis Communication during COVID-19: English, French, Portuguese, and Spanish Discourse of AstraZeneca Vaccine and Omicron Variant on Social Media
by: Daniel Catalan-Matamoros, et al.
Published: (2023-06-01) -
ANCA-associated vasculitis following Oxford-AstraZeneca COVID-19 vaccine in Brazil: Is there a causal relationship? A case report
by: Welder Zamoner, et al.
Published: (2022-10-01) -
Side Effects Following Administration of the First Dose of Oxford-AstraZeneca’s Covishield Vaccine in Bangladesh: A Cross-Sectional Study
by: Nishat Jahan, et al.
Published: (2021-10-01)